Venture-Backed Startups

Enyday offers an app and automated platform for operating energy communities, managing shared solar installations across multiple homes and calculating hourly, individual electricity bills based on variable prices and tariffs. It serves property developers, housing associations, municipalities, and commercial buildings in Denmark.

1 investor

Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field. This page lists the venture capital and institutional firms that back the company.

3 investors

Enyx provides FPGA-based solutions and development frameworks for financial trading applications, enabling developers to build high-performance trading engines and market data processing systems with reduced time-to-market.

1 investor

Enza Group is an organization with a global leadership structure spanning multiple regions, led by executives managing technology, operations, commercial, and financial functions across West Africa, Ghana, and Southern Africa.

1 investor

Enzai builds an AI governance and compliance platform that helps enterprises manage, monitor, and audit AI systems while scaling deployment responsibly. The platform provides centralized AI inventory management, automated risk assessments, and real-time oversight for organizations in regulated industries.

4 investors

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals. It is a subsidiary of Alkem Laboratories and offers advanced manufacturing processes as a strategic partner for biologic products.

1 investor

0 investors

Enzia is an early-stage venture capital firm whose team of sector-focused investors backs entrepreneurs in areas such as education and healthcare. It positions itself as a hands-on partner supporting founders through due diligence, growth, and operational execution.

1 investor

Enzidia operates an enzyme engineering platform that combines ultra-high-throughput screening (its MillionFull technology) with AI-directed evolutionary loops to optimize enzymes and cell factory strains for biomanufacturing. It partners with industrial biotech companies to improve bioprocess efficiency and generate large labeled enzyme sequence-performance datasets.

1 investor

Enzinc develops zinc micro-sponge anode battery technology for energy storage, working to bring production-ready battery systems to market through battery manufacturing partners. The company operates R&D and manufacturing facilities in the San Francisco Bay Area (Richmond and Oakland, California).

3 investors

0 investors

Enzo is an AI-native software platform built specifically for home health agencies, unifying intake, scheduling, documentation, OASIS, coding, QA, billing, quality management, and reporting on a single system. It automates routine work and flags cases needing human review, addressing home health workflows such as PDGM, RAP/NOA, and episode-based care.

2 investors

1 investor

Enzuzo provides a consent management platform specifically designed for online ticketing and event platforms. The solution helps event organizers and ticketing companies manage attendee privacy compliance, optimize checkout conversions, and maintain global regulatory compliance during high-traffic sales periods.

1 investor

0 investors

Enzyme develops a Quality Management System (QMS) software platform for life science companies including drug, biologic, device, and digital product manufacturers, designed to streamline regulatory workflows and generate FDA-ready documentation.

1 investor

0 investors

Enzymedica manufactures and sells dietary supplements and probiotics designed to support digestive health, joint function, sleep, and stress relief. Products are marketed as science-backed formulas using natural ingredients.

1 investor

Enzymlogic provides kinetic profiling of compounds to support early-stage drug discovery, focusing on the Hit to Lead and Lead Optimization phases. Using protein science and high-throughput screening assays, it delivers kinetic data on compound-target interactions to pharmaceutical and biotech organizations to help them prioritize promising molecules.

1 investor

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.

1 investor

Enzyva develops engineered enzyme systems that treat complex industrial wastewater in a single step under harsh conditions such as high pH, high salinity, and toxic chemicals. It initially targets textile industry effluents, with the aim of expanding to other water-intensive sectors including pharma, food, cosmetics, chemicals, and mining.

1 investor

EO is a verification and intelligence layer for deployed GPU compute infrastructure, converting fragmented hardware telemetry into a continuously verified record of each asset's identity, condition, custody, degradation, and economic value. It serves compute operators, capital providers, insurers, and hardware buyers, providing a shared state layer used for financing, optimization, insurance, resale, and servicing.

2 investors

EO Charging provides electric vehicle charging solutions and fleet electrification services. The company operates charging infrastructure and management platforms for fleet operators.

1 investor

EODev is a French industrial company specializing in zero-emission energy production and storage systems, with a focus on hydrogen-powered technologies and battery systems for stationary, mobile, and marine applications. The company serves manufacturers, local authorities, and industrial sectors seeking to transition to decarbonized solutions for mobility and heavy industries.

1 investor